Abstract
The paper investigates the dynamic landscape of personalized medicine in European healthcare, focusing on the multifaceted application of biomarkers in chronic disease management from 2013 to 2023. Beginning with an exploration of the concept of personalized medicine, the study underscores the pivotal role of biomarkers in tailoring medical interventions to individual patient characteristics. The research methodology incorporates a systematic literature review, primary research studies, and case analyses to provide a comprehensive overview. Exemplary applications in oncology, cardiovascular diseases, and diabetes illuminate the transformative impact of biomarkers on treatment outcomes. The paper also navigates challenges such as data privacy, ethical considerations, and disparities in access, while highlighting opportunities for further research and improvement. Through collaborative efforts between healthcare professionals, researchers, and industry partners, personalized medicine emerges as a promising paradigm in reshaping the landscape of chronic disease management in Europe.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
